AMPK, insulin resistance, and the metabolic syndrome

被引:684
作者
Ruderman, Neil B. [1 ,2 ,3 ]
Carling, David [4 ]
Prentki, Marc [5 ,6 ,7 ,8 ]
Cacicedo, Jose M. [1 ,2 ,3 ]
机构
[1] Boston Univ, Diabet & Metab Res Unit, Sch Med, Boston, MA 02118 USA
[2] Boston Univ, Dept Med, Sch Med, Boston, MA 02118 USA
[3] Boston Univ, Endocrinol Sect, Sch Med, Boston, MA 02118 USA
[4] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Hammersmith Hosp, Cellular Stress Grp, London, England
[5] Univ Montreal, Montreal Diabet Res Ctr, Montreal, PQ, Canada
[6] Univ Montreal, CRCHUM, Montreal, PQ, Canada
[7] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada
[8] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada
基金
英国医学研究理事会;
关键词
ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; MUSCLE GLUCOSE-METABOLISM; NITRIC-OXIDE SYNTHASE; FATTY-ACID OXIDATION; ADIPOSE-TISSUE; MALONYL-COA; SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; BARIATRIC SURGERY;
D O I
10.1172/JCI67227
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Insulin resistance (IR) and hyperinsulinemia are hallmarks of the metabolic syndrome, as are central adiposity, d.yslipidemia, and a predisposition to type 2 diabetes, atherosclerotic cardiovascular disease, hypertension, and certain cancers. Regular exercise and calorie restriction have long been known to increase insulin sensitivity and decrease the prevalence of these disorders. The subsequent identification of AMP-activated protein kinase (AMPK) and its activation by exercise and fuel deprivation have led to studies of the effects of AMPK on both IR and metabolic syndrome-related diseases. In this review, we evaluate this body of literature, with special emphasis on the hypothesis that dysregulation of AMPK is both a pathogenic factor for these disorders in humans and a target for their prevention and therapy.
引用
收藏
页码:2764 / 2772
页数:9
相关论文
共 151 条
[91]   Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes [J].
Prentki, Marc ;
Madiraju, S. R. Murthy .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 353 (1-2) :88-100
[92]   SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function [J].
Price, Nathan L. ;
Gomes, Ana P. ;
Ling, Alvin J. Y. ;
Duarte, Filipe V. ;
Martin-Montalvo, Alejandro ;
North, Brian J. ;
Agarwal, Beamon ;
Ye, Lan ;
Ramadori, Giorgio ;
Teodoro, Joao S. ;
Hubbard, Basil P. ;
Varela, Ana T. ;
Davis, James G. ;
Varamini, Behzad ;
Hafner, Angela ;
Moaddel, Ruin ;
Rolo, Anabela P. ;
Coppari, Roberto ;
Palmeira, Carlos M. ;
de Cabo, Rafael ;
Baur, Joseph A. ;
Sinclair, David A. .
CELL METABOLISM, 2012, 15 (05) :675-690
[93]   Cidea is associated with lipid droplets and insulin sensitivity in humans [J].
Puri, Vishwajeet ;
Ranjit, Srijana ;
Konda, Silvana ;
Nicoloro, Sarah M. C. ;
Straubhaar, Juerg ;
Chawla, Anil ;
Chouinard, My ;
Lin, Chenyi ;
Burkart, Alison ;
Corvera, Silvia ;
Perugini, Richard A. ;
Czech, Michael P. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (22) :7833-7838
[94]   Inverse Regulation of Inflammation and Mitochondrial Function in Adipose Tissue Defines Extreme Insulin Sensitivity in Morbidly Obese Patients [J].
Qatanani, Mohammed ;
Tan, Yejun ;
Dobrin, Radu ;
Greenawalt, Danielle M. ;
Hu, Guanghui ;
Zhao, Wenqing ;
Olefsky, Jerrold M. ;
Sears, Dorothy D. ;
Kaplan, Lee M. ;
Kemp, Daniel M. .
DIABETES, 2013, 62 (03) :855-863
[95]   Calcium/Calmodulin-dependent Protein Kinase Kinase 2: Roles in Signaling and Pathophysiology [J].
Racioppi, Luigi ;
Means, Anthony R. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (38) :31658-31665
[96]   ROLE OF INSULIN RESISTANCE IN HUMAN-DISEASE [J].
REAVEN, GM .
DIABETES, 1988, 37 (12) :1595-1607
[97]   MUSCLE GLUCOSE-METABOLISM FOLLOWING EXERCISE IN THE RAT - INCREASED SENSITIVITY TO INSULIN [J].
RICHTER, EA ;
GARETTO, LP ;
GOODMAN, MN ;
RUDERMAN, NB .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (04) :785-793
[98]   AMPK and the biochemistry of exercise: implications for human health and disease [J].
Richter, Erik A. ;
Ruderman, Neil B. .
BIOCHEMICAL JOURNAL, 2009, 418 :261-275
[99]   AMP kinase and malonyl-CoA: Targets for therapy of the metabolic syndrome [J].
Ruderman, N ;
Prentki, M .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :340-351
[100]   The metabolically obese, normal-weight individual revisited [J].
Ruderman, N ;
Chisholm, D ;
Pi-Sunyer, X ;
Schneider, S .
DIABETES, 1998, 47 (05) :699-713